Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ovarian Neoplasms

  Free Subscription


11.12.2017

1 Anticancer Drugs
1 BMC Cancer
1 Cancer
2 Cancer Lett
2 Gynecol Oncol
1 Hum Pathol
1 Int J Cancer
1 Obstet Gynecol
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Drugs

  1. ASSI T, Kourie HR, El Rassy E, Moussa T, et al
    Response of an ovarian granulosa cell tumor with everolimus and exemestane after initial response to letrozole.
    Anticancer Drugs. 2017;28:931-933.
    PubMed     Text format     Abstract available


    BMC Cancer

  2. SMITS S, Boivin J, Menon U, Brain K, et al
    Influences on anticipated time to ovarian cancer symptom presentation in women at increased risk compared to population risk of ovarian cancer.
    BMC Cancer. 2017;17:814.
    PubMed     Text format     Abstract available


    Cancer

  3. STEWART SL, Harewood R, Matz M, Rim SH, et al
    Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.
    Cancer. 2017;123 Suppl 24:5138-5159.
    PubMed     Text format     Abstract available


    Cancer Lett

  4. YANG Z, Jin P, Xu S, Zhang T, et al
    Dicer reprograms stromal fibroblasts to a pro-inflammatory and tumor-promoting phenotype in ovarian cancer.
    Cancer Lett. 2017;415:20-29.
    PubMed     Text format     Abstract available

  5. YANG X, Wang CC, Lee WYW, Trovik J, et al
    Long non-coding RNA HAND2-AS1 inhibits invasion and metastasis in endometrioid endometrial carcinoma through inactivating neuromedin U.
    Cancer Lett. 2017 Oct 26. pii: S0304-3835(17)30665.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  6. HAMILTON CA, Miller A, Casablanca Y, Horowitz NS, et al
    Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study.
    Gynecol Oncol. 2017 Nov 28. pii: S0090-8258(17)31528.
    PubMed     Text format     Abstract available

  7. URBAN RR, He H, Alfonso R, Hardesty MM, et al
    The end of life costs for Medicare patients with advanced ovarian cancer.
    Gynecol Oncol. 2017 Dec 3. pii: S0090-8258(17)31533.
    PubMed     Text format     Abstract available


    Hum Pathol

  8. XING D, Rahmanto YS, Zeppernick F, Hannibal CG, et al
    Mutation of NRAS is a Rare Genetic Event in Ovarian Low-Grade Serous Carcinoma.
    Hum Pathol. 2017 Sep 2. pii: S0046-8177(17)30303.
    PubMed     Text format     Abstract available


    Int J Cancer

  9. KHAIRALLAH AS, Genestie C, Auguste A, Leary A, et al
    Impact of neoadjuvant chemotherapy on the immune microenvironment in advanced epithelial ovarian cancer: Prognostic and therapeutic implications.
    Int J Cancer. 2017 Dec 8. doi: 10.1002/ijc.31200.
    PubMed     Text format    


    Obstet Gynecol

  10. PASCUAL MA, Graupera B, Pedrero C, Rodriguez I, et al
    Long-term Results for Expectant Management of Ultrasonographically Diagnosed Benign Ovarian Teratomas.
    Obstet Gynecol. 2017 Nov 3. doi: 10.1097/AOG.0000000000002327.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  11. STONE ML, Chiappinelli KB, Li H, Murphy LM, et al
    Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden.
    Proc Natl Acad Sci U S A. 2017 Dec 4. pii: 1712514114.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: